Brief: Novonesis Q1 Adjusted EBITDA Up At EUR 412.8 Million
May 8 (Reuters) - Novozymes A/S NSISb.CO: OUTLOOK: FY ADJUSTED EBITDA MARGIN 37-38% Q1 NET SALES EUR 1,077.6 MILLION Q1 ADJUSTED EBITDA EUR 412.8 MILLION VERSUS EUR 303.3 MILLION YEAR AGO 2025 OUTLOOK MAINTAINED ON TARIFFS: DOES NOT EXPECT SIGNIFICANT ADVERSE NET IMPACT FROM HIGHER TRADE TARIFFS Source text: ID:nGNEycVvX Further company coverage: [NSISb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novozymes A/S
See all newsGivaudan jumps on fragrance outperformance; peers follow
Europe Research Roundup: IWG, Londonmetric, Sartorius
Brief: Novonesis To Build Next Generation Enzyme Production Facility In India
Next cycle in ingredient makers sector belongs to biotech, Jefferies says
Europe Research Roundup: DSM-Firmenich, Merck, Orsted